The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The plasma therapy market has witnessed a significant surge in recent years, with promising forecasts indicating further expansion. This growth is propelled by various factors such as the rising prevalence of chronic diseases, increased awareness of plasma therapy benefits, and government support.

Market Size and Growth Projections

• The plasma therapy market size is expected to reach $0.55 billion in 2024, with a Compound Annual Growth Rate (CAGR) of 11.4%.
• Projections suggest a substantial growth to $0.88 billion by 2028, exhibiting a CAGR of 12.5%.
• Factors driving this growth include the adoption of immunoglobulins, expanding applications, and rising demand for personalized therapies.

Factors Driving Growth

• Rising prevalence of chronic diseases
• Increased awareness of plasma therapy benefits
• Government support and reimbursement coverage
• Growing demand for minimally invasive procedures
• Rising demand for personalized medicine
• Growing geriatric population

Trends Shaping the Future

• Development of new and improved plasma therapy techniques
• Advancements in biological manufacturing
• Emergence of cell-free plasma therapies
• Integration of telemedicine
• Exploration of new applications through research

View More On The Plasma Therapy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Increasing Osteoarthritis Cases Boost Demand

• Osteoarthritis cases are on the rise globally, projecting a significant increase by 2050.
• Platelet-rich plasma (PRP) emerges as a safe and effective treatment for osteoarthritis, offering symptomatic relief and slowing disease progression.
• Major companies in the plasma therapy market include Takeda Pharmaceutical, Bio Products Laboratory, and Arthrex Inc.

New Product Launches To Address Evolving Treatment Needs

• Major companies are introducing innovative products like the ESG-410 to cater to evolving needs.
• The ESG-410, an Electrosurgical Generator, enhances treatment options for non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH).
• Olympus Corporation launched the ESG-410 in June 2023, featuring advanced design elements for superior plasma stability.

Market Segmentation The plasma therapy market is segmented based on:

1. Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
2. Application: Orthopedics, Arthritis, Dermatology, Plastic Surgery, and more
3. End-Users: Hospitals & Clinics, Research Institutes

Regional Insights

• North America led the plasma therapy market in 2023.
• The Middle East is anticipated to be the fastest-growing region during the forecast period.

Request A Sample Of The Global Plasma Therapy Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3278&type=smp